Long-Term Supervised Treatment Interruption in HIV-Infected Patients

Mise à jour : Il y a 4 ans
Référence : NCT00118677

Femme et Homme

  • | Pays :
  • France
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This trial is aimed at studying the safety of long term supervised treatment interruption in HIV infected patients with CD4 over 350/mm3 and plasma HIV RNA under 50 000/mL. Another aim of this study is to assess the immunological and virological factors associated with the duration of treatment interruption.


Critère d'inclusion

  • HIV Infections

Liens